CN201186082Y - Intelligent input mechanism for insulins and glucose - Google Patents
Intelligent input mechanism for insulins and glucose Download PDFInfo
- Publication number
- CN201186082Y CN201186082Y CNU2008203006616U CN200820300661U CN201186082Y CN 201186082 Y CN201186082 Y CN 201186082Y CN U2008203006616 U CNU2008203006616 U CN U2008203006616U CN 200820300661 U CN200820300661 U CN 200820300661U CN 201186082 Y CN201186082 Y CN 201186082Y
- Authority
- CN
- China
- Prior art keywords
- glucose
- insulin
- diabetes
- blood sugar
- pump
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Images
Landscapes
- External Artificial Organs (AREA)
Abstract
The utility model discloses an insulin and glucose intelligent input device, which comprises a microcomputer controller (2) which is connected with an insulin pump (1) and is also connected with a glucose input pump (4) and a blood sugar monitor chip (3). The insulin and glucose intelligent input device has the advantages of avoiding hypoglycemia, satisfying the blood sugar demand in different physiological condition, adjusting internal environment finely, little influence from external environment, reducing the limit of diet and sport for patients to the larger degree and fitting for all diabetes patients, in particular to the group who has worse insula function or higher blood sugar demand: 1. senile diabetes, 2. pregnancy diabetes, 3. 1 staged diabetes, 4. operation period diabetes.
Description
Technical field
This utility model relates to a kind of insulin, the input equipment of glucose intelligence, belongs to diabetes Medical Instruments technical field.
Background technology
Insulin is the hormone of unique blood sugar lowering in the human body, is a kind of main treatment means of diabetes, at present mainly by the size of medical worker according to blood sugar effects setting insulin input quantity, by seven sections blood glucose of monitoring in a day, to regulate insulin dose.Because the some blood glucose of each monitoring is subjected to interference factor extremely many, and beyond measuring point blood glucose in the time, even the too high or too low threat to life that all can affect the treatment of blood glucose.Input quantity was not accurate enough when therefore existing insulin pump used.
Summary of the invention
The purpose of this utility model is: a kind of insulin, the input equipment of glucose intelligence are provided, can analyze dynamic blood sugar effects, according to the blood glucose value boundary of setting up, management insulin pump and glucose front pump are to reach better medical effect.
This utility model is to constitute like this: it comprises microcomputer controller 2, and microcomputer controller 2 connects insulin pump 1, and microcomputer controller 2 also is connected with glucose front pump 4 and blood sugar monitoring chip 3.
Above-mentioned insulin, the input equipment of glucose intelligence, glucose front pump 4 passes through pipeline 5 to the body 6 of human body.
Above-mentioned insulin, the input equipment of glucose intelligence are in the body 6 of blood sugar monitoring chip 3 implant into body.
Above-mentioned insulin, the input equipment of glucose intelligence, microcomputer controller 2 is connected with alarm 7.
This utility model is set up the constant input quantity of insulin by per 25 minutes clockwise microcomputer controller feedbacks of blood sugar monitoring chip blood glucose value according to the body condition of using the patient, sets blood glucose value L-H, when blood glucose is lower than L, stops to import insulin; Start the glucose front pump; When being higher than H, strengthen the input quantity of insulin pump, keep blood glucose value in set point.When being lower than 3.9mmol/L (hypoglycemia), import a certain amount of glucose, keep blood glucose value in normal range by microcomputer controller control glucose front pump as microcomputer controller monitoring blood glucose value.Compare with prior art, the utlity model has following advantage: avoid hypoglycemia; Can satisfy under the different physiological statuss requirement to blood glucose; Environment in the energy finely regulating, the less influence that is subjected to external environment can reduce the restriction that the patient is subjected to diet, motion largely; Can be used for all diabeticss, be particularly useful for following islet function crowd relatively poor or that blood glucose is had relatively high expectations: 1, senile diabetes; 2, gestational diabetes; 3, type 1 diabetes; 4, peri-operation period diabetes.
Description of drawings
Accompanying drawing 1 is a structural representation of the present utility model.
The specific embodiment
Embodiment of the present utility model: the insulin input system that adopts the existing market to sell, comprise microcomputer controller 2, microcomputer controller 2 connects insulin pump 1, and insulin pump 1 is connected to human body body 6 by pipeline, and microcomputer controller 2 is according to blood glucose fluctuation horizontal adjustment insulin input quantity.Microcomputer controller 2 also is connected with glucose front pump 4 and blood sugar monitoring chip 3.Glucose front pump 4 adopts and insulin pump 1 similar products like, and blood sugar monitoring chip 3 adopts existing subcutaneous blood sugar monitoring chip.Glucose front pump 4 is passed through pipeline 5 to the body 6 of human body, in the body 6 of blood sugar monitoring chip 3 implant into body.Microcomputer controller 2 is connected with alarm 7.Alarm 7 can adopt and the similar alarm device of existing insulin input system, its effect is, when the amount of liquid of insulin, glucose during near bottom line, conveyance conduit stops up, when coming off, alarm 7 sends a kind of alarm tone prompting, reminds patient or medical personnel to handle.When blood sugar level was higher or lower than set scope, alarm 7 sent another kind of alarm tone prompting, but does not need artificial processing.
During use, set up the constant input quantity of insulin, set blood glucose value L-H, when blood glucose is lower than L, stop to import insulin according to the body condition of using the patient; Start glucose front pump 4, import a certain amount of glucose, return to the intermediate value of L and H up to blood glucose value after, stop the input of glucose, restart insulin pump 1 and carry out the input of constant basis.When blood glucose value is higher than H, strengthen the input quantity of insulin pump 1, return to the intermediate value of L and H when blood glucose value after, carry out the input of constant basis again.
Claims (4)
1. an insulin, the input equipment of glucose intelligence, it comprises microcomputer controller (2), microcomputer controller (2) connects insulin pump (1), and it is characterized in that: microcomputer controller (2) also is connected with glucose front pump (4) and blood sugar monitoring chip (3).
2. insulin according to claim 1, the input equipment of glucose intelligence, it is characterized in that: glucose front pump (4) passes through pipeline (5) to the body (6) of human body.
3. insulin according to claim 1, the input equipment of glucose intelligence is characterized in that: in the body (6) of blood sugar monitoring chip (3) implant into body.
4. insulin according to claim 1, the input equipment of glucose intelligence, it is characterized in that: microcomputer controller (2) is connected with alarm (7).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNU2008203006616U CN201186082Y (en) | 2008-05-05 | 2008-05-05 | Intelligent input mechanism for insulins and glucose |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNU2008203006616U CN201186082Y (en) | 2008-05-05 | 2008-05-05 | Intelligent input mechanism for insulins and glucose |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN201186082Y true CN201186082Y (en) | 2009-01-28 |
Family
ID=40309095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNU2008203006616U Expired - Fee Related CN201186082Y (en) | 2008-05-05 | 2008-05-05 | Intelligent input mechanism for insulins and glucose |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN201186082Y (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102500013A (en) * | 2011-11-22 | 2012-06-20 | 北京化工大学 | Fully automatic intelligent infusion method and device based on model predictive control for large doses of insulin |
| CN106456064A (en) * | 2014-01-31 | 2017-02-22 | 波士顿大学董事会 | Offline glucose control based on preceding periods |
| US10940267B2 (en) | 2019-07-16 | 2021-03-09 | Beta Bionics, Inc. | Blood glucose control system with real-time glycemic control optimization |
| US11154656B2 (en) | 2019-07-16 | 2021-10-26 | Beta Bionics, Inc. | Blood glucose control system with medicament bolus recommendation |
| US11744945B2 (en) | 2015-08-07 | 2023-09-05 | Trustees Of Boston University | Glucose control system with automatic adaptation of glucose target |
| US11957876B2 (en) | 2019-07-16 | 2024-04-16 | Beta Bionics, Inc. | Glucose control system with automated backup therapy protocol generation |
-
2008
- 2008-05-05 CN CNU2008203006616U patent/CN201186082Y/en not_active Expired - Fee Related
Cited By (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102500013A (en) * | 2011-11-22 | 2012-06-20 | 北京化工大学 | Fully automatic intelligent infusion method and device based on model predictive control for large doses of insulin |
| CN106456064A (en) * | 2014-01-31 | 2017-02-22 | 波士顿大学董事会 | Offline glucose control based on preceding periods |
| US10543313B2 (en) | 2014-01-31 | 2020-01-28 | Trustees Of Boston University | Glucose level control system with offline control based on preceding periods of online control |
| US11744945B2 (en) | 2015-08-07 | 2023-09-05 | Trustees Of Boston University | Glucose control system with automatic adaptation of glucose target |
| US10940267B2 (en) | 2019-07-16 | 2021-03-09 | Beta Bionics, Inc. | Blood glucose control system with real-time glycemic control optimization |
| US10960137B2 (en) | 2019-07-16 | 2021-03-30 | Beta Bionics, Inc. | Blood glucose control system with automated backup therapy protocol generation |
| US11116902B2 (en) | 2019-07-16 | 2021-09-14 | Beta Bionics, Inc. | Blood glucose control system with control parameter modification |
| US11154656B2 (en) | 2019-07-16 | 2021-10-26 | Beta Bionics, Inc. | Blood glucose control system with medicament bolus recommendation |
| US11744947B2 (en) | 2019-07-16 | 2023-09-05 | Beta Bionics, Inc. | Glucose control system with control parameter modification |
| US11766518B2 (en) | 2019-07-16 | 2023-09-26 | Beta Bionics, Inc. | Glucose level control system with control parameter modification |
| US11941392B2 (en) | 2019-07-16 | 2024-03-26 | Beta Bionics, Inc. | Ambulatory medical device with malfunction alert prioritization |
| US11957876B2 (en) | 2019-07-16 | 2024-04-16 | Beta Bionics, Inc. | Glucose control system with automated backup therapy protocol generation |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN201186082Y (en) | Intelligent input mechanism for insulins and glucose | |
| US11786656B2 (en) | Cloud big data-based system and method for insulin pump individualized configuration optimization | |
| US10166331B2 (en) | Automatic closed-loop control adjustments and infusion systems incorporating same | |
| EP1110085B1 (en) | System for blood glucose determination | |
| JP6243546B2 (en) | Offline glucose level control based on preceding period | |
| CN103418053B (en) | Individualized insulin treatment pump and basic infusion rate optimization method thereof | |
| JP6062859B2 (en) | Program, computer readable medium, drug delivery controller and method | |
| KR20190132684A (en) | Consideration of remaining insulin in the artificial pancreas system | |
| US20130046281A1 (en) | Closed Loop Infusion Formulation Delivery System | |
| CN110289094B (en) | Expert rule-based insulin accurate administration decision method | |
| EP4325520A3 (en) | System coordinator and modular architecture for open-loop and closed-loop control of diabetes | |
| JP2003522558A (en) | Closed loop system for controlling insulin infusion | |
| CN101254322A (en) | Portable intelligent insulins curing pump and control model thereof | |
| WO2019222485A3 (en) | Method and system to treat acute decompensated heart failure | |
| CN101579544A (en) | Automatically regulating infusion method and device | |
| CN113117180A (en) | Unilateral driving closed-loop artificial pancreas | |
| CN202010328U (en) | Temperature-adjustable infusion pump | |
| Wolpert | A Clinician's Perspective on Some of the Challenges in" Closing the Loop" | |
| CN205698707U (en) | artificial pancreas | |
| Prud'Homme et al. | Preclinically assessed optimal control of postprandial glucose excursions for type 1 patients with diabetes | |
| CN205181355U (en) | But blood sugar tests early warning system of automatic calculation insulin shot | |
| CN210933231U (en) | Intelligent management system is treated to domestic oxygen of bronchopulmonary dysplasia infant | |
| Pyrlis et al. | Recent advances in management of type 1 diabetes | |
| Hu et al. | The design of an intelligent insulin pump | |
| CN112370607B (en) | Insulin pump therapeutic instrument |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090128 Termination date: 20110505 |